Biocon Limited (NSE:BIOCON)
India flag India · Delayed Price · Currency is INR
330.05
-0.55 (-0.17%)
Jun 6, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Biosimilars
88.18B
Log In
Log In
Log In
Log In
Upgrade
Biosimilars Growth
58.61%
Log In
Log In
Log In
Log In
Upgrade
Research
34.37B
Log In
Log In
Log In
Log In
Upgrade
Research Growth
9.50%
Log In
Log In
Log In
Log In
Upgrade
Generics
25.00B
Log In
Log In
Log In
Log In
Upgrade
Generics Growth
1.80%
Log In
Log In
Log In
Log In
Upgrade
Novels
-
Log In
Log In
Log In
Log In
Upgrade
Novels Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biologics
-
Log In
Log In
Log In
Log In
Upgrade
Biologics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Branded Formulations
-
Log In
Log In
Log In
Log In
Upgrade
Branded Formulations Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
United States
64.55B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
55.80%
Log In
Log In
Log In
Log In
Upgrade
European Union (Including Ireland)
35.17B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
31.76B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-24.01%
Log In
Log In
Log In
Log In
Upgrade
India
16.08B
Log In
Log In
Log In
Log In
Upgrade
India Growth
-3.93%
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
-
Log In
Log In
Log In
Log In
Upgrade